Mary Wilson
Well-known member
Volume 29, Number 11—November 2023
DOI: 10.3201/eid2911.230836
LaRinda A. Holland[SUP]1[/SUP], Steven C. Holland[SUP]1[/SUP], Matthew F. Smith, Victoria R. Leonard, Vel Murugan, Lora Nordstrom, Mary Mulrow, Raquel Salgado, Michael White, and Efrem S. Lim
Abstract
We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022–April 2023 in Arizona, USA. We identified mutations within prefusion F-protein antigenic sites in both subtypes. Continued genomic surveillance will be critical to ensure RSV vaccine effectiveness.
https://wwwnc.cdc.gov/eid/article/29/11/23-0836_article
DOI: 10.3201/eid2911.230836
LaRinda A. Holland[SUP]1[/SUP], Steven C. Holland[SUP]1[/SUP], Matthew F. Smith, Victoria R. Leonard, Vel Murugan, Lora Nordstrom, Mary Mulrow, Raquel Salgado, Michael White, and Efrem S. Lim
Abstract
We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022–April 2023 in Arizona, USA. We identified mutations within prefusion F-protein antigenic sites in both subtypes. Continued genomic surveillance will be critical to ensure RSV vaccine effectiveness.
https://wwwnc.cdc.gov/eid/article/29/11/23-0836_article